Common questions about FluMist Quadrivalent (FAQ)
Q: Can children under 2 years old use FluMist Quadrivalent?
A: According to official product information, FluMist Quadrivalent is approved for use only in persons 2 through 49 years of age. It is not approved for use in children younger than 2 years of age because clinical trials indicated an increased risk of hospitalization and wheezing in this age group.
Q: What should I know about using FluMist Quadrivalent if I have asthma?
A: Official information indicates that individuals with asthma, as well as children younger than 5 years of age with recurrent wheezing, may have an increased risk of wheezing after administration. This vaccine has not been studied in persons with active wheezing or severe asthma.
Q: Can FluMist Quadrivalent be used if I've recently taken an antiviral drug for the flu?
A: Antiviral medicines that work against influenza (like oseltamivir or zanamivir) may reduce the effectiveness of this vaccine. For this reason, the vaccine administration should be delayed until at least 48 hours after the cessation of antiviral medicine, as described in administration constraints. Similarly, official regulatory constraints indicate that influenza antiviral agents should be withheld for two weeks following vaccination.
Q: Is FluMist Quadrivalent suitable for people with weakened immune systems?
A: No. Official labeling states that the vaccine is contraindicated, meaning it must not be used, in people who are immunocompromised. This is due to the risk of the live attenuated (weakened) virus components causing a disseminated infection. The effectiveness of the vaccine is also not established in this population.
Q: What if I sneeze right after getting the FluMist Quadrivalent spray?
A: It is normal to experience a slight tickle or sneezing with the nasal application. Regulatory guidance suggests that revaccination is not typically needed because the vaccine is formulated to ensure an adequate immune response is initiated, accounting for expected minor loss.
Q: Does FluMist Quadrivalent require refrigeration or special storage?
A: Yes, official regulatory documents outline specific storage conditions. The vaccine must be kept in a refrigerator between 2°C and 8°C (35°F and 46°F). The vaccine must not be frozen at any time, as this affects the stability of the live viral components. It should also be kept in its original carton to protect it from light.
Q: Do the side effects of FluMist Quadrivalent feel like having a mild flu?
A: The most common reported adverse reactions found in regulatory documents may feel similar to a mild flu. These reactions, such as runny nose, nasal congestion, headache, sore throat, and tiredness, are often mild and temporary. Fever is also listed as a reported reaction, particularly in children 2 through 6 years of age.
Q: Are there any known issues with getting FluMist Quadrivalent and other vaccines at the same time?
A: Studies and public health guidance indicate that FluMist Quadrivalent can be administered at the same time as inactivated (non-live) vaccines. If it is administered with another live injectable vaccine, official constraints indicate it should either be given on the same day or separated by at least four weeks to ensure the intended immune response.
Q: How long does the protection from FluMist Quadrivalent last?
A: Official clinical studies typically monitor protection for the course of a single influenza season. Because the effectiveness of the vaccine may decline over time, and the circulating viral strains often change, public health guidance recommends receiving the vaccination annually.
Q: Is FluMist Quadrivalent appropriate for adults over 50?
A: No. The official indication from regulatory bodies states that the vaccine is approved for use in persons 2 through 49 years of age. Use of the vaccine is not approved for those 50 years of age and older.
Q: Can I use FluMist Quadrivalent if I have a cold?
A: Official guidance indicates that minor illnesses, with or without a fever, do not generally prevent the use of the vaccine. However, administration should be delayed if nasal congestion is significant enough to prevent the vaccine from being delivered properly into the nose.
Q: Is FluMist Quadrivalent safe to use if I am around people with compromised immunity?
A: Official regulatory constraints describe a need for recipients to attempt to avoid close association with severely immunocompromised individuals (those requiring a protected environment) for a period of 1 to 2 weeks after administration. This is a precaution against the potential for transmission of the live attenuated virus.
Q: Are there specific food or drink interactions with FluMist Quadrivalent?
A: Official regulatory documents define the interaction profile of this vaccine primarily through other medicines. No specific interactions with food, alcohol, or herbal products are documented in the official labeling for this product.
Q: Are there any religious or cultural restrictions on using FluMist Quadrivalent components?
A: Official composition documents list the ingredients, including trace residuals of components such as porcine-derived gelatin hydrolysate and ovalbumin (egg protein). These ingredients are listed for transparency, as they may be relevant to individuals with certain religious or cultural dietary restrictions.
Q: What types of research studies were conducted on FluMist Quadrivalent before approval?
A: Prior to approval, studies included randomized, double-blind, and active-controlled clinical trials. These studies primarily focused on determining the efficacy and safety of the vaccine by monitoring outcomes related to the rates of laboratory-confirmed influenza in the studied populations of healthy children and adults.
Q: What is the difference between FluMist Trivalent and Quadrivalent?
A: The term 'Quadrivalent' refers to the vaccine’s composition, meaning it is formulated to protect against four strains of the influenza virus. This includes two Influenza A subtypes and two Influenza B lineages, which is one more B lineage than the previous 'Trivalent' formulation.
Q: Can I still get the flu after using FluMist Quadrivalent?
A: Official product information states that the vaccine may not protect all individuals who receive it. The vaccine is also designed to prevent disease caused by the specific strains contained within the formulation, but not all circulating influenza strains that may cause illness.
Q: What kind of evidence is available about FluMist Quadrivalent’s performance in different seasons?
A: The strains included in the vaccine are determined and updated annually based on global predictions of the most likely circulating viruses for that flu season. The effectiveness of any flu vaccine, including FluMist Quadrivalent, is known to vary each season depending on how well the vaccine strains match the strains that actually circulate.
Q: Does FluMist Quadrivalent interact with common pain relievers like Tylenol or Advil?
A: The only contraindication regarding pain relievers in the official regulatory documents relates to the use of aspirin or salicylate-containing therapy in children and adolescents. No specific drug interactions with non-salicylate pain relievers like acetaminophen (Tylenol) or ibuprofen (Advil) are typically documented in the official labeling.
Q: What are the ingredients in FluMist Quadrivalent besides the active virus components?
A: The active components are the live attenuated influenza virus reassortants. Non-medicinal ingredients listed in the official documents include several components such as porcine-derived gelatin hydrolysate, sucrose, monosodium glutamate, and trace residuals of ovalbumin (egg protein) and gentamicin. The vaccine does not contain preservatives like thimerosal.
Q: Is it possible to receive FluMist Quadrivalent more than once in the same flu season?
A: For individuals 9 through 49 years of age, the vaccine is indicated for use once per influenza season. Children 2 through 8 years of age may be indicated to receive two doses, but these must be given at least one month apart, based on their prior vaccination history.
Q: Is FluMist Quadrivalent associated with any sleep disturbances?
A: Sleep disturbances are not listed among the very common or common solicited (expected) adverse reactions found in the official regulatory documents. Tiredness or weakness, however, is a very common reaction that has been reported.
Q: What if I feel unwell a few days after receiving FluMist Quadrivalent?
A: Reports from clinical trials note that some individuals experienced mild reactions following administration. These may include common side effects like headache, runny nose, sore throat, tiredness, and sometimes fever, which are generally temporary.
Q: What is the minimum amount of time required between using FluMist Quadrivalent and taking a flu antiviral?
A: To avoid potential interference with the vaccine’s effect, official guidance requires that antiviral agents active against influenza A and/or B be withheld for two weeks following the administration of FluMist Quadrivalent.
Q: Are there any specific lifestyle changes needed after using FluMist Quadrivalent?
A: Official regulatory constraints describe a need for recipients to attempt to avoid close association with severely immunocompromised individuals (those requiring a protected environment) for 1 to 2 weeks after administration. No other specific post-administration lifestyle changes are generally documented as necessary in the official regulatory labeling.
